今开:15.15 | 昨收:15.13 |
最高:15.165 | 最低:15.13 |
涨停价:0.0 | 跌停价:0.0 |
总市值:2.23748023E8 |
Merrimack(MACK)05-09 19:55
$Merrimack(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-134775 Act: 34 Size: 56 KB 网页链接查看全文
Merrimack(MACK)03-22 21:55
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-074722 Act: 34 Size: 56 KB 网页链接查看全文
Merrimack(MACK)03-28 05:05
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-078910 Act: 34 Size: 194 KB 网页链接查看全文
Merrimack(MACK)03-28 05:05
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-078920 Act: 34 Size: 53 KB 网页链接查看全文
Merrimack(MACK)03-06 05:45
$Merrimack制药(MACK)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-24-059357 Act: 34 Size: 1 MB 网页链接查看全文
Merrimack(MACK)03-08 01:35
$Merrimack制药(MACK)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001086364-24-007251 Act: 34 Size: 12 KB 网页链接查看全文
Merrimack(MACK)03-08 05:45
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-062260 Act: 34 Size: 187 KB 网页链接查看全文
Merrimack(MACK)03-08 05:45
$Merrimack制药(MACK)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-24-062268 Act: 34 Size: 49 KB 网页链接查看全文
Merrimack(MACK)03-08 05:25
$Merrimack制药(MACK)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-027966 Act: 34 Size: 5 MB 网页链接查看全文
Merrimack(MACK)02-23 05:55
$Merrimack制药(MACK)$ SCHEDULE 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001758866-24-000002 Act: 34 Size: 15 KB 网页链接查看全文
囧尼2014-09-28 14:25
9/29 watchlist:$Cross Country Healthcare(CCRN)$ $Federated National(FNHC)$ $Karyopharm Therapeutics(KPTI)$ $Merrimack(MACK)$ $Magellan Petroleum(MPET)$ $OVASCIENCE INC(OVAS)$ $Sonic(SONC)$ $CIVEO CORP(CVEO)$ $哈尼斯品牌服装(HBI)$查看全文
Tanthius2014-05-06 06:07
LIST1,$Merrimack(MACK)$ ,$艾菲矩阵(AFFX)$ ,$HYPERDYNAMICS CORP(HDY)$ ,$Orbitz(OWW)$ ,$阿罗特克(ARTX)$ ,$标记临床研究(XOMA)$ ,$PCO(PCO)$查看全文
Tanthius2014-04-16 06:03
LIST2,$SYNTHETIC BIOLOGICS INC(SYN)$ ,$通用钢铁(GSI)$ ,$Oxigene(OXGN)$ ,$Merrimack(MACK)$ ,$Noranda Aluminum控股(NOR)$ ,$美世国际(MERC)$ ,$THERAPEUTICSMD INC(TXMD)$查看全文
Tanthius2014-03-27 04:38
LIST2,$Merrimack(MACK)$ ,$伊克力西斯(EXEL)$ ,$DOCUMENT SEC SYS INC(DSS)$ ,$韩华新能源(HSOL)$ ,$单片机微系统(INVE)$ ,$李氏企业(LEE)$ ,$Dyax(DYAX)$ ,$爱克莱恩(ACHN)$ ,$ELEPHANT TALK COMM CORP(ETAK)$查看全文
Tanthius2014-03-19 05:36
LIST2,$SIBANYE GOLD LTD(SBGL)$ ,$Merrimack(MACK)$ ,$快辑半导体(QUIK)$ ,$超视野传播(EVC)$ ,$海湾资源(GURE)$ ,$阿尔法泰克控股(ATEC)$查看全文
智通财经APP获悉,周三,美国生物技术公司Merrimack Pharma(MACK.US)的法国癌症治疗合作伙伴Ipsen S.A.宣布,其药物Onivyde作为一种组合疗法,在一种胰腺癌的后期试验中达到了主要终点。截至发稿,Merrimack Pharma盘前涨238.75%,报13.... 网页链接
$Merrimack(MACK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-24-060478 Act: 34 Size: 3 MB 网页链接
$Merrimack(MACK)$ 25 Notification of the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001193125-24-136243 Act: 34 Size: 12 KB 网页链接
$Merrimack(MACK)$ 8-K Current report, items 5.07, 7.01, and 9.01 Accession Number: 0001193125-24-136237 Act: 34 Size: 189 KB 网页链接
$Merrimack(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-134775 Act: 34 Size: 56 KB 网页链接
$Merrimack(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-134773 Act: 34 Size: 197 KB 网页链接
$Merrimack(MACK)$ 8-K Current report, items 3.01, 7.01, and 9.01 Accession Number: 0001193125-24-125367 Act: 34 Size: 201 KB 网页链接
$Merrimack(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-125372 Act: 34 Size: 59 KB 网页链接
$Merrimack(MACK)$ DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001193125-24-083441 Act: 34 Size: 619 KB 网页链接
$Merrimack制药(MACK)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-24-078910 Act: 34 Size: 194 KB 网页链接
$Merrimack制药(MACK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-078920 Act: 34 Size: 53 KB 网页链接